The story of Sildenafil presents a nuanced case for investors in the drug sector. While initially a tremendous success, generating vast sums, the exclusivity lapse and the subsequent entry of cheaper versions have https://viagra091916.activosblog.com/40314404/the-little-copyright-and-pharma-a-risky-play